Advanced Search
Contact | Corporate | Help

Daily news email for July 23, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Sartorius Stedim Biotech Recognized as Innovations Honoree for FlexMoSys

New Campaign for Rentschler's 'Facility of the Year'

Berthold Awards Marlene DeLuca Prices

Berthold Launches TriStar² Microplate Reader

Encap Announces $ 2 Million Capital Expenditure Programme

 BioSpace
Caisson Biotech, LLC Appoints Biotechnology Veteran Glenn Nedwin CEO and President

Pfizer Inc. Loses Prempro Ruling, Must Pay $10.4 Million

Kowa Pharmaceuticals America, Eli Lilly and Company Release Results From a Pharmacokinetic Study

How Breast Cancer Cells Damage Bones, Peter MacCallum Cancer Centre Study

Would Higher Severance be the Solution for Merck KGaA Workers

BioSpace - Breaking News
Cerulean Pharma Inc. Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer

Repros Therapeutics Inc.' Proellex®-V Shows Consistent Efficacy in Uterine Fibroids Phase 2 Study

Depomed, Inc. Announces Publication of Phase 3 Data from Gralise (gabapentin) Clinical Trial

OncoSec Medical Inc. OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies

Orexo AB Reports Positive Feedback from Pre-NDA Meeting With FDA - Clearing Path for Regulatory Submission of OX219

Biotech News - Business Wire
Research and Markets: Biobanks - 2012 Year Book

Nation's Largest Bundled Payment Collaborative Helping Health Systems Succeed in Public and Private Market Arrangements

RTI Biologics Schedules 2012 Second Quarter Earnings and Conference Call for July 31, 2012

Aurora Imaging Technology Announces Exclusive China Distribution Agreement With SUMEC Group Corporation

Research and Markets: European Directory of Biotechnology Companies 2012-2013

 Biotech News - PR Newswire
AAAS To Host Live Online Discussion On 2013 U.S. Federal R&D Budget

Ronald L. Chez Files Amended 13D and Letter to the Board

Chimerix's Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study

Leading India-USA based CRO Announces Data Management/EDC, Medical Writing Milestone

First Plant Genomics Yield Technology Progresses
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Tools Companies Expand in Diagnostics

FDA approves Onyx Multiple Myeloma Drug

First Gene Therapy Gets EU Backing

MedImmune to Cut 200 Jobs in California

Confidence Shaken

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
The Penumbra START Trial Points to Imaging Technique That Could Predict Good Outcome for Acute Ischemic Stroke Patients

Resumen: Un grupo consultivo de la FDA revisará el sistema de prótesis de retina Argus® II de Second Sight

Samenvatting: FDA beoordeelt Argus II Retinal Prosthesis System van bedrijf Second Sight

FDA Panel Scheduled to Review Second Sight's Argus® II Retinal Prosthesis System

Un groupe consultatif de la FDA va examiner le système de prothèse rétinienne Argus® II de Second Sight

 Clinical Trials - PR Newswire
Eastern Health Goes Live with NexJ Disease Screening

Drug safety and efficacy in children is rarely addressed in drug trials for major diseases

World-renowned Fragile X experts to announce major breakthrough findings July 26

Psychiatric Times Features Special Coverage on Sleep Disorders

New Research Reported At The Alzheimer's Association® International Conference Advances Validation Of New Diagnostic Guidelines

 CNN Top Stories
Penn State gets 'stark wake-up call'

Public gets 1st look at suspect

Holmes appears dazed

Surfer: Shark started shaking me

Opinion: Economy weak before crash
Contract Pharma
Financial Reports: Jubilant Life Sciences 1Q13

Sandoz Completes Fougera Acquisition

Synergy To Acquire Callisto

Nuvo Research Earns Galderma Milestone

Beta Pharma To Manufacture Sunshine Drug

 FDA Drugs- What's New
FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)

FDA Drug Safety Communication: Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment

 FDA News - Business Wire
Dr. Robert Melamede, CEO, Cannabis Science, Presents at World AIDS Institute Legislative Briefing

Head-to-Head Study Comparing Navidea's AZD4694 to the Gold Standard for Imaging Beta Amyloid Protein Deposits Presented at Alzheimer's Association International Conference

Pfizer Reports Top-Line Results of Study of Lyrica's Effect on Male Reproduction Conducted as a Post-Approval Commitment Required by the U.S. Food and Drug Administration

Orexo Reports Positive Feedback from Pre-NDA Meeting with FDA Clearing Path for Regulatory Submission of OX219

The International Myeloma Foundation Says FDA Approval of Kyprolis Gives Patients a Critical New Option
FDA Press Releases
FDA: More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief

FDA warns consumers not to eat shellfish from Oyster Bay Harbor, Nassau County, NY

FDA approves Afinitor for advanced breast cancer

FDA approves Kyprolis for some patients with multiple myeloma

FDA approves weight-management drug Qsymia

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

 FierceBiotech
Can Merck's suvorexant wake up the lethargic market for sleep drugs

PTC investors back lead orphan drug with $30M round

Chiasma snares $38.5M to fund final PhIII drive

Boehringer buys PhII respiratory drug program

Can Merck's suvorexant wake up the lethargic market for new sleep drugs
FierceBiotech IT
10 Reasons Why Biotech Needs Big Data

WorldOne takes over Sermo social network for docs

Medidata CEO seeks organic growth over big eClinical buyouts

Pfizer builds credentials as 'data company'

Venter, Stanford build first computer model of complete organism

 FierceBiotech Research
New class of Alzheimer's drugs looks promising in animals

New compound nearly wipes out HIV in cells

Drugs targeting APJ to combat cardiovascular diseases can cause greater harm

Hopkins study exposes potential schizophrenia drug target

New 'molecular grenade' used to attack tumor cells

 FiercePharma
Search for cheap prices sets stage for more counterfeit drugs

Onyx staffs up for Kyprolis' assault on myeloma market

Geneva workers stiff-arm Merck KGaA severance offer

J&J appeals $1.2B Risperdal marketing fine

Nexavar fails combo trial, but keeps liver cancer crown
FiercePharma Manufacturing
Baxter inks supply deal for key blood-derived meds

Novartis' Q2 sales hit after Excedrin production woes

Sanofi plant adds 40 to produce SkyePharma product

India kicks track and trace further down the road

Docs reportedly get smuggled cancer drugs in Pakistan bazaar

 FierceVaccines
Animal model replicates human response to HIV

Sanofi, Pitt team to develop universal seasonal flu vaccine

Oral vax rides on advanced microparticles

Galena stock jumps with NeuVax patent

HIV-positive patients approved for smallpox vax in an emergency

 Health News - BizJournals.com
Missouri Health Connection names Kasal as first CEO

Via Christi adds clinical practice VP

Waukesha Memorial undertakes major renovation

Thousands attend sale at Hawaii Medical Center West

Chronic-pain drug developer Relmada raises $3M
Health News - CNBC
Economy, budget woes threaten U.S. non-profit hospitals: Moody's

FDA warns about seizures with MS drug Ampyra

Economy, budget woes threaten non-profit hospitals: Moody's

Onyx, Astellas say liver drug combination fails

Perrigo sells Fla. manufacturing plant to Medline

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
EA Wins $27M EPA Contract Renewal

VC Investors Shun Biotech Startups

LMI Names New Senior Vice President for Resource Management

Scorecard Chides Administration on Synthetic Bio Policy Follow-Up

GSK Finally Bags HGS in $3B Deal
Marketwire - Pharma and Biotech
Home Medical Equipment Industry and Major Non-Profit Advocacy Groups to Unite at Medtrade

Mid Coast Hospital Streamlines Urgent Care Desktops Using VMware View(TM), Cisco UCS, and Atlantis ILIO

Knovel Offers Yaws' Critical Property Data for Chemical Engineers and Chemists

Sunshine Heart Announces First Patient Reaches Two-Year Follow-Up Mark for C-Pulse(R) Heart Assist System

Trimel Completes Patient Enrolment of CompleoTRT(TM) Phase III Trial

 MassBio News
2012 Tax Incentive Program Announcement

Q&A With Jonathan Thomas

Policy Update

BioPharm America: MassBio to host partnering event

Patient Profile: Radio Personality Lends Voice to Advocacy Efforts

 Medical Pharma - PR Newswire
Bench International Adds Catherine Balin to Executive Team

Shady Grove Fertility Center Releases 2011 IVF Success Rates

Faith in Sobriety: The New Way to Recover

Medifast Expands Meal Replacement Line with New Medifast to go! Products

Expanded Fistula Program to Help Hundreds More Women in Tanzania
National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

 Nature Biotechnology
Incorporating biomarkers into clinical trial designs: points to consider

TAL effector RVD specificities and efficiencies

Gene therapy matures in the clinic

From academic solos to industrial symphonies

Reading cancer's blueprint

 New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment
New York Times- Pharmaceuticals
Glaxo and Rival Drug Firm Are Said to Be Near a Deal

F.D.A. Approves Afinitor and Kyprolis for Breast Cancer and Myeloma

Kerry Kennedy Cites Possible Seizure in Car Crash

Some Legal Clarity on Generic Drugs

F.D.A. Approves Qsymia, a Weight-Loss Drug

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
Research and Markets: Gaucher's Disease - Pipeline Review, H1 2012

IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 FIELDS 1 GOAL Campaign

Rite Aid Makes Back-to-School Shopping Easy for Students of All Ages & All Budgets

Research and Markets: Cardiogenic Shock - Pipeline Review, H1 2012

July 23rd: Intl AIDS Conference Satellite SessionThe HIV Testing Crisis: 34 Million with HIV, Only 14 Million Know it

 Pharma News - PharmiWeb
National Industries for the Blind to Ensure Accessibility of Buildium's Property Management Software

New SEEDS Supplier Added to Premier's Physical Therapy Products and Exercise Equipment Portfolio

Jupiter Medical Center Selects Kronos to Help Support Quality Care Delivery While Keeping Financial Goals in Mind

Greyson International, Inc. Receives Notice of Allowance from the U.S. Patent and Trademark Office for its Breakthrough Trilexon® Delivery System Technology

Mid Cheshire Hospitals NHS Foundation Trust order Ascribe's award winning eHandover solution

 Pharma News - PR Newswire
Diplomat Specialty Pharmacy's 2012 Physician Satisfaction Survey Results Affirm Success of Company's Education & Training Program

Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.

InterMune Reports Second Quarter 2012 Financial Results and Business Highlights

OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies

Webcast Alert: Isis Pharmaceuticals' Second Quarter 2012 Financial Results Conference Call
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
ATCC Now Offers the Big Six E. coli Strains for Food Safety Testing

Global E-Clinical Trial Technologies Market to Reach US$1.37 Billion...

SPIE Acts in Support of Affordable Library Pricing for Fourth Straight...

Rust Remover Shopping Spree: Rusterizer Cuts 10% From Non-Toxic Rust...

Path to Finding Optimal Protein Biotherapeutic Gives Rise to New...
PRWeb - Pharmaceuticals
The White House and the Center for Safe Internet Pharmacies Join...

Baby Mantra Wins Best of the Press Award at the NPA Marketplace 2012

Pacific Bridge Medical, a Premier Medical Consulting Firm Specializing...

New Protease Inhibitors Encourage More Immediate HCV Treatment, but...

New Anti Aging Moisturizer For Men And Women Best New Product Launch...

 Scientific American
Europe Nears First Approval for Gene Therapy Treatment

Artificial Jellyfish Built from Rat Cells

International AIDS Conference Returns to U.S. with Much Remaining Undone

From Living Room to Lily Pad: Is the Fatal Amphibian Chytrid Fungus Spread via Pet Frogs

Sequencing of Single Sperm Could Reveal New Infertility Causes

 Sports - ESPN Basketball
UF lands Walker, new No. 1 in 2013 recruiting

Akron, coach Dambrot agree on 10-year deal

Source: NCAA clears Kansas freshman Doyle

NIT tourneys reach 3-year extention with MSG

Lawyer says Syracuse violated law in Fine case
Sports News - ESPN
PSU: $60M fine, 4-year bowl ban, wins to 1998

2011 ACC Media Days

Ex-Texas Tech, S. Carolina coach Carlen dies

Swofford: ACC's focus 'totally on 14' schools

Pryor's mentor from Ohio State scandal dead

 Xconomy Life Sciences
Scarcity of Samples Threatens Personalized Medicine

Woeful Websites: How to Guarantee Your Startup Wont Get Funding

Woeful Websites: How to Guarantee Your Start-Up Wont Get Funding

Scarcity of Samples Poses Threat To Personalized Medicine

Onyx Gets FDA Approval For New Myeloma Drug; Stock Climbs

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012